Activated tumour necrosis factor-α shedding process is associated with in-hospital complication in patients with acute myocardial infarction

Clinical Science

Volumn 108, Issue 4, 2005, Pages 339-347

  Shimoda, Yudai ^a   Satoh, Mamoru ^a   Nakamura, Motoyuki ^a   Akatsu, Tomonari ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Flow cytometer; Median fluorescence intensity; Peripheral blood mononuclear cell; TACE (TNF converting enzyme); TNF (tumour necrosis factor )

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ACUTE HEART INFARCTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; AGED; ARRHYTHMIA; CELLS, CULTURED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17144373309     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040229     Document Type: Article

References (24)

1. Maekawa, Y., Anzai, T., Yoshikawa, T. et al. (2002) Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J. Am. Coll. Cardiol. 39, 241-246
2. Furman, M. I., Gore, J. M., Anderson, F. A. et al. (2004) Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am. Heart J. 147, 42-48
3. Tashiro, H., Shimokawa, H., Yamamoto, K. et al. (1995) Monocyte-related cytokines in acute myocardial infarction. Am. Heart J. 130, 446-452
4. Marx, N., Neumann, F. J., Ott, I. et al. (1997) Induction of cytokine expression in leukocytes in acute myocardial infarction. J. Am. Coll. Cardiol. 30, 165-170
5. Black, R. A., Rauch, C. T., Kozlosky, C. J. et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature (London) 385, 729-733
6. Moss, M. L., Jin, S. L., Milla, M. E. et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature (London) 385, 733-736
7. Black, R. A. (2002) Tumor necrosis factor-α converting enzyme. Int. J. Biochem. Cell. Biol. 34, 1-5
8. Zhang, Z., Oliver, P., Lancaster, Jr, J. R. et al. (2001) Reactive oxygen species mediate tumor necrosis factor α-converting-enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15, 303-305
9. Doedens, J. R. and Black, R. A. (2000) Stimulation-induced down-regulation of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275, 14598-14607
10. Conway, J. G., Andrews, R. C., Beaudet, B. et al. (2001) Inhibition of tumor necrosis factor-α (TNF-α) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-α-converting enzyme and matrix metalloproteinases. J. Pharmacol. Exp. Ther. 298, 900-908
11. Dekkers, P. E., Lauw, F. N., ten Hove, T. et al. (1999) The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-α (TNF-α) and TNF-α receptors during human endotoxemia. Blood 94, 2252-2258
12. Diwan, A., Dibbs, Z., Nemoto, S., DeFreitas, G. et al. (2004) Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation 109, 262-268
13. Akatsu, T., Nakamura, M., Satoh, M. and Hiramori, K. (2003) Increased mRNA expression of tumour necrosis factor-α and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin. Sci. 105, 39-44
14. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159
15. Shirai, T., Yamaguchi, H., Ito, H., Todd, C. W. and Wallace, R. B. (1985) Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature (London) 313, 803-806
16. de Jager, W., te Velthuis, H., Prakken, B. J., Kuis, W. and Rijkers, G. T. (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10, 133-139
17. Latini, R., Bianchi, M., Correale, E. et al. (1994) Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J. Cardiovasc. Pharmacol. 23, 1-6
18. Mann, D. L. (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 91, 988-998
19. Anker, S. D. and von Haehling, S. (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90, 464-470
20. Peschon, J. J., Slack, J. L., Reddy, P. et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284
21. Biasucci, L. M., Liuzzo, G., Angiolillo, D. J., Sperti, G. and and Maseri, A. (2000) Inflammation and acute coronary syndromes. Herz 25, 108-112
22. Bozkurt, B., Kribbs, S. B., Clubb, Jr, F. J. et al. (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97, 1382-1391
23. Sliwa, K., Skudicky, D., Candy, G., Wisenbaugh, T. and Sareli, P. (1998) Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351, 1091-1093
24. Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G. and Maseri, A. (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107, 857-863